Latest News about AMGN
Recent news which mentions AMGN
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
From Benzinga
The 3 Best Healthcare Stocks to Buy in July 2024
July 04, 2024
From InvestorPlace
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
From Motley Fool
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 24, 2024
From Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
From Benzinga
From InvestorPlace
3 Stocks to Buy as Ozempic Surges in Popularity
June 13, 2024
From InvestorPlace
From Motley Fool
Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal
June 05, 2024
From Benzinga
From Motley Fool
From Benzinga
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
May 29, 2024
From Benzinga
From InvestorPlace
From Motley Fool
From Benzinga
From InvestorPlace
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
May 21, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.